Vivek Shinde

6.3k total citations
31 papers, 1.3k citations indexed

About

Vivek Shinde is a scholar working on Epidemiology, Infectious Diseases and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Vivek Shinde has authored 31 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Epidemiology, 12 papers in Infectious Diseases and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Vivek Shinde's work include Influenza Virus Research Studies (17 papers), Respiratory viral infections research (13 papers) and Pneumonia and Respiratory Infections (8 papers). Vivek Shinde is often cited by papers focused on Influenza Virus Research Studies (17 papers), Respiratory viral infections research (13 papers) and Pneumonia and Respiratory Infections (8 papers). Vivek Shinde collaborates with scholars based in United States, Belgium and South Africa. Vivek Shinde's co-authors include François Haguinet, Roger Lustig, Zendi Solano, Lina S. Sy, Hung Fu Tseng, Gonçalo Matias, Cynthia Schuck‐Paim, Bradley K. Ackerson, Christine A. Fischetti and Yi Luo and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Vivek Shinde

27 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vivek Shinde United States 20 1.1k 426 304 120 103 31 1.3k
Charles Sande United Kingdom 20 967 0.9× 378 0.9× 521 1.7× 144 1.2× 185 1.8× 33 1.2k
Sarah S. Long United States 12 835 0.8× 221 0.5× 204 0.7× 59 0.5× 76 0.7× 22 1.0k
Santtu Heinonen Finland 15 652 0.6× 348 0.8× 220 0.7× 162 1.4× 114 1.1× 32 1.1k
Andrea M. Collins United Kingdom 21 800 0.7× 337 0.8× 156 0.5× 191 1.6× 94 0.9× 54 1.2k
Lars‐Magnus Andersson Sweden 18 317 0.3× 541 1.3× 81 0.3× 51 0.4× 77 0.7× 44 923
James McMenamin United Kingdom 10 636 0.6× 289 0.7× 104 0.3× 62 0.5× 30 0.3× 18 844
Sylvie Behillil France 17 388 0.4× 598 1.4× 93 0.3× 63 0.5× 125 1.2× 27 1.1k
Monika Redlberger‐Fritz Austria 15 480 0.4× 245 0.6× 91 0.3× 84 0.7× 37 0.4× 44 655
Nan-Chang Chiu Taiwan 13 259 0.2× 321 0.8× 83 0.3× 33 0.3× 46 0.4× 28 739
Kenneth J. Mutton United Kingdom 14 672 0.6× 382 0.9× 160 0.5× 53 0.4× 69 0.7× 26 918

Countries citing papers authored by Vivek Shinde

Since Specialization
Citations

This map shows the geographic impact of Vivek Shinde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vivek Shinde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vivek Shinde more than expected).

Fields of papers citing papers by Vivek Shinde

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vivek Shinde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vivek Shinde. The network helps show where Vivek Shinde may publish in the future.

Co-authorship network of co-authors of Vivek Shinde

This figure shows the co-authorship network connecting the top 25 collaborators of Vivek Shinde. A scholar is included among the top collaborators of Vivek Shinde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vivek Shinde. Vivek Shinde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Bennett, Chijioke, Zaheer Hoosain, Anthonet Koen, et al.. (2024). Immunogenicity and safety of SARS-CoV-2 recombinant spike protein vaccine in South African people living with and without HIV-1 infection: A phase 2 randomised trial. Journal of Infection. 89(6). 106285–106285. 2 indexed citations
3.
Stertman, Linda, Anna-Karin E. Palm, Berit Carow, et al.. (2023). The Matrix-M™ adjuvant: A critical component of vaccines for the 21 st century. Human Vaccines & Immunotherapeutics. 19(1). 2189885–2189885. 59 indexed citations
4.
Dunkle, Lisa M., Shabir A. Madhi, Cynthia L. Gay, et al.. (2023). Safety, efficacy, and immunogenicity of the NVX-CoV2373 vaccine. Expert Review of Vaccines. 22(1). 501–517. 20 indexed citations
5.
Shinde, Vivek, et al.. (2023). Asthma: Types, Pathophysiology and Herbal remedies. Asian Journal of Research in Pharmaceutical Sciences. 161–166.
6.
Herring, William L., Yuanhui Zhang, Vivek Shinde, et al.. (2021). Clinical and economic outcomes associated with respiratory syncytial virus vaccination in older adults in the United States. Vaccine. 40(3). 483–493. 26 indexed citations
7.
Shinde, Vivek, Rongman Cai, Joyce S. Plested, et al.. (2020). Induction of Cross-Reactive Hemagglutination Inhibiting Antibody and Polyfunctional CD4+ T-Cell Responses by a Recombinant Matrix-M–Adjuvanted Hemagglutinin Nanoparticle Influenza Vaccine. Clinical Infectious Diseases. 73(11). e4278–e4287. 20 indexed citations
8.
Korsten, Koos, Niels Adriaenssens, Samuel Coenen, et al.. (2020). Burden of respiratory syncytial virus infection in community-dwelling older adults in Europe (RESCEU): an international prospective cohort study. European Respiratory Journal. 57(4). 2002688–2002688. 79 indexed citations
9.
Colosia, Ann, Jin Yang, Eric Hillson, et al.. (2017). The epidemiology of medically attended respiratory syncytial virus in older adults in the United States: A systematic review. PLoS ONE. 12(8). e0182321–e0182321. 77 indexed citations
10.
11.
Matias, Gonçalo, Robert J. Taylor, François Haguinet, et al.. (2017). Estimates of hospitalization attributable to influenza and RSV in the US during 1997–2009, by age and risk status. BMC Public Health. 17(1). 271–271. 100 indexed citations
12.
Fries, Louis, Vivek Shinde, Jeffrey J. Stoddard, et al.. (2017). Immunogenicity and safety of a respiratory syncytial virus fusion protein (RSV F) nanoparticle vaccine in older adults. Immunity & Ageing. 14(1). 8–8. 61 indexed citations
13.
Cohet, Catherine, François Haguinet, Gaël Dos Santos, et al.. (2016). Effect of the adjuvanted (AS03) A/H1N1 2009 pandemic influenza vaccine on the risk of rejection in solid organ transplant recipients in England: a self-controlled case series. BMJ Open. 6(1). e009264–e009264. 23 indexed citations
14.
Effelterre, Thierry Van, Gaël Dos Santos, & Vivek Shinde. (2016). Twin Peaks: A/H1N1 Pandemic Influenza Virus Infection and Vaccination in Norway, 2009–2010. PLoS ONE. 11(3). e0151575–e0151575. 12 indexed citations
15.
Santos, Gaël Dos, François Haguinet, Catherine Cohet, et al.. (2016). Risk of solid organ transplant rejection following vaccination with seasonal trivalent inactivated influenza vaccines in England: A self-controlled case-series. Vaccine. 34(31). 3598–3606. 21 indexed citations
16.
Bollaerts, Kaatje, Vivek Shinde, Gaël Dos Santos, et al.. (2016). Application of Probabilistic Multiple-Bias Analyses to a Cohort- and a Case-Control Study on the Association between Pandemrix™and Narcolepsy. PLoS ONE. 11(2). e0149289–e0149289. 9 indexed citations
17.
Verstraeten, Thomas, Catherine Cohet, Gaël Dos Santos, et al.. (2015). Pandemrix™ and narcolepsy: A critical appraisal of the observational studies. Human Vaccines & Immunotherapeutics. 12(1). 187–193. 29 indexed citations
18.
Shinde, Vivek, Wanna Hanshaoworakul, James Mark Simmerman, et al.. (2011). A Comparison of Clinical and Epidemiological Characteristics of Fatal Human Infections with H5N1 and Human Influenza Viruses in Thailand, 2004–2006. PLoS ONE. 6(4). e14809–e14809. 20 indexed citations
19.
Hanshaoworakul, Wanna, James Mark Simmerman, Vivek Shinde, et al.. (2009). Severe Human Influenza Infections in Thailand: Oseltamivir Treatment and Risk Factors for Fatal Outcome. PLoS ONE. 4(6). e6051–e6051. 106 indexed citations
20.
Buss, Bryan, Vivek Shinde, Thomas J. Safranek, & Timothy M. Uyeki. (2009). Pediatric influenza‐associated myositis – Nebraska, 2001–2007. Influenza and Other Respiratory Viruses. 3(6). 277–285. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Charles Sande Breakdown of academic impact, for papers by Sarah S. Long Breakdown of academic impact, for papers by Santtu Heinonen Breakdown of academic impact, for papers by Andrea M. Collins Breakdown of academic impact, for papers by Lars‐Magnus Andersson Breakdown of academic impact, for papers by James McMenamin Breakdown of academic impact, for papers by Sylvie Behillil Breakdown of academic impact, for papers by Monika Redlberger‐Fritz Breakdown of academic impact, for papers by Nan-Chang Chiu Breakdown of academic impact, for papers by Kenneth J. Mutton
Rankless by CCL
2026